Cooley Advises Cell Therapy Biz On London Market Exit
MaxCyte Inc. said Tuesday that it plans to quit the junior Alternative Investment Market in London — but will continue to list on the Nasdaq in New York where a large...To view the full article, register now.
Already a subscriber? Click here to view full article